The Cigna GroupCI
Close of Friday, October 23, 2026 · The Cigna Group is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$306.92
vs its Pivot
+9.2%
OnlyAlpha Score
76
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +15.6% | +13.4% | +2.0% | +1.4% | +10.3% |
Dividend: $6.19 a share over the last 12 months, a 2.02% yield at today's price.
Who runs and owns it
In these funds
Suppliers, customers and partners
Sells to CI
| Cencora | ~13% of revenue (Evernorth) |
| United Therapeutics | Accredo; Tyvaso via spec. distributors 59% of rev |
CI sells to
| Centene | Express Scripts PBM agreement |
| Jazz Pharmaceuticals | ESSDS exclusive central pharmacy (Xywav/Xyrem) |
Partners and deals
| Prime Therapeutics (private) | Express Scripts-Prime agreements |
From the companies' own annual reports filed with the SEC.
Healthcare · Health insurers and PBMs
Get CI in your free daily emailAfter every close: whether CI is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CI free → Full Stock check
Track CI free → Full Stock check